Appointment

15th September, 2026 The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Sub: Disclosure under Regulation 30(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (“SEBI LODR Regulations”): Appointment of Senior Management Personnel Dear Sir(s)/Madam, Pursuant to Regulation 30 of the SEBI LODR Regulations, we wish to inform you that Dr. Shubhadeep Sinha has been appointed at senior management position in the Company effective from 15th September, 2026. Further, the details as required in terms of Regulation 30 read with Schedule III, Part A of the SEBI LODR Regulations and SEBI Master Circular bearing HO/49/14/14(7)2025CFDPOD2/I/3762/2026 dated January 30, 2026 is provided in Annexure I to this letter. The above information is also available on the website of the Company www.alkemlabs.com. Kindly take the same on your records. Sincerely, For Alkem Laboratories Limited Divya Kumar Vice President – Legal & Deputy Company Secretary Encl: a/a Annexure I Sr. No. Particulars Details 1. Name Dr. Shubhadeep Sinha 2. Reason for change viz. appointment, Appointment re-appointment, resignation, removal, death or otherwise 3. Date of appointment/ Date of appointment: 15th September, 2026 re-appointment/ cessation (as applicable) and term of Term of Appointment: Duration of the contract appointment/ re-appointment shall be so long as he is in employment of the Company. 4. Brief profile Dr. Shubhadeep Sinha is a distinguished healthcare and pharmaceutical professional with over 25 years of experience in Clinical Development, Medical Affairs, Pharmacovigilance, Regulatory Affairs, and Healthcare Management. 5. Disclosure of relationships between Not Applicable directors